丽珠医药(01513)拟公开要约收购IMP股份事宜正式收到越南国家证券委员会出具的同意本次交易的批复文件

智通财经03-06

智通财经APP讯，丽珠医药(01513)发布公告，本公司于2025年5月22日召开了第十一届董事会第二十五次会议，于2025年12月30日召开了第十一届董事会第三十一次会议(统称“相关董事会”)，审议通过了《关于拟收购越南IMP公司股权的议案》及《关于拟公开要约收购越南IMP公司股权的议案》，同意LIANSGPHOLDINGPTE.LTD.(LIANSGP)根据越南相关规定，向越南国家证券委员会(...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2617681094?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-03-06 18:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2617681094","market":"fut","top_or_hot":-1,"title":"丽珠医药(01513)拟公开要约收购IMP股份事宜正式收到越南国家证券委员会出具的同意本次交易的批复文件","media":"智通财经","content":"<div>\n<p>智通财经APP讯，丽珠医药(01513)发布公告，本公司于2025年5月22日召开了第十一届董事会第二十五次会议，于2025年12月30日召开了第十一届董事会第三十一次会议(统称“相关董事会”)，审议通过了《关于拟收购越南IMP公司股权的议案》及《关于拟公开要约收购越南IMP公司股权的议案》，同意LIANSGPHOLDINGPTE.LTD.(LIANSGP)根据越南相关规定，向越南国家证券委员会(...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1411090.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>丽珠医药(01513)拟公开要约收购IMP股份事宜正式收到越南国家证券委员会出具的同意本次交易的批复文件</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n丽珠医药(01513)拟公开要约收购IMP股份事宜正式收到越南国家证券委员会出具的同意本次交易的批复文件\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-06 18:56 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1411090.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，丽珠医药(01513)发布公告，本公司于2025年5月22日召开了第十一届董事会第二十五次会议，于2025年12月30日召开了第十一届董事会第三十一次会议(统称“相关董事会”)，审议通过了《关于拟收购越南IMP公司股权的议案》及《关于拟公开要约收购越南IMP公司股权的议案》，同意LIANSGPHOLDINGPTE.LTD.(LIANSGP)根据越南相关规定，向越南国家证券委员会(...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1411090.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FT_SY_FVN","symbol_name":"富时越南30指数","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1411090.html","article_id":"2617681094","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2617681094","pubTimestamp":1772794588,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"本公司董事会欣然宣布，本公司境外全资子公司LIANSGP已根据本公司相关董事会决议，就本次拟公开要约收购IMP股份事宜向越南国家证券委员会提交相关申请，且已正式收到越南国家证券委员会出具的同意本次交易的批复文件。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"161027":"证券","01513":"丽珠医药","BK1191":"制药"},"translate_title":"Livzon Pharmaceutical (01513) proposed to make a public tender offer to acquire IMP shares officially received the approval document issued by the National Securities Commission of Vietnam approving this transaction","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"161027":1.5,"FVNmain":1.5,"01513":1.5},"content_text":"智通财经APP讯，丽珠医药(01513)发布公告，本公司于2025年5月22日召开了第十一届董事会第二十五次会议，于2025年12月30日召开了第十一届董事会第三十一次会议(统称“相关董事会”)，审议通过了《关于拟收购越南IMP公司股权的议案》及《关于拟公开要约收购越南IMP公司股权的议案》，同意LIANSGPHOLDINGPTE.LTD.(LIANSGP)根据越南相关规定，向越南国家证券委员会(StateSecurities Commission)申请公开要约收购IMP股份，并向IMP全体股东公开发出收购要约。本公司董事会欣然宣布，本公司境外全资子公司LIANSGP已根据本公司相关董事会决议，就本次拟公开要约收购IMP股份事宜向越南国家证券委员会提交相关申请，且已正式收到越南国家证券委员会出具的同意本次交易的批复文件。本公司将积极推进本次交易的相关事宜。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,merge","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2617681094","isCrawlerRequest":true}